“showed a trend”

Low baseline tumor infiltrating CD20+ B cells showed a trend towards association with worse clinical response (p = 0.07; N = 24).

The superficial motor cortex showed a trend toward increased percent area of CD31+ blood vessels in NA‐CI mice (3.97% ± 1.15%, n = 9) compared to NA‐PBS mice (3.16% ± 0.81%, n = 7, p ≤ 0.07; Figure 4B ).

Trials using more than 500 μg per day of selenium showed a trend towards a lower mortality (RR = 0.80, 95% CI 0.63 to 1.02, P = 0.07) whereas trials using doses lower than 500 μg had no effect on mortality (RR 0.94, 95% CI 0.67 to 1.33, P = 0.75).

female) sex showed a trend toward lower risks of overall (aHR 0.67, 95% CI 0.43–1.04, p = 0.07) and nonliver‐related (aHR 0.72, 95% CI 0.45–1.14, p = 0.16) mortality. 3 Discussion In this real‐world longitudinal cohort study of MASLD patients with PSM to balance background characteristics of the two sex subgroups, we found that the overall, nonliver‐related, and liver‐related mortality rates were similar between males and females overall.

IL‐8 also showed a trend to be reduced on day 3 in the OZA group ( P = 0.07; Figure 3b ) and P‐ values are reported for other cytokines such as C–X–C motif ligand (CXCL) 13, interferon‐γ, tumor necrosis factor and IL‐6 (Figure 3c–f ; see Supplementary figure 3 for the remaining analytes).

HH) showed a trend toward greater aggression reactivity scores in women who were homozygous for the H allele compared with those with one or two L alleles ( F (1, 328) = 3.40, P = 0.07, partial η 2 = 0.010).

BRAF mut/MSS cancers showed a trend for increasing rates of CIN coinciding with spread to at least one lymph node (p = 0.07).

In the EU group EGR3 SNP rs1877670 showed a trend toward association (p = 0.07), and the ARC SNP rs35900184 revealed a significant association with the schizophrenia diagnosis (p = 0.02).

The corresponding additive DAT1 and COMT effects on the visual N700 following non-target stimuli which had been preceded by the cue ‘A’ showed a trend for DAT1 (t = 1.8; p = 0.07) but no effect of COMT (t = 0.7; p = 0.48), while the interaction between DAT1 and COMT reached trend level in this case (t = 1.8; p = 0.08).

MAF of rs1061376 showed a trend towards a lower frequency in hypertensive patients [0.3 vs. 0.34; OR (T) = 0.83 (95%CI: 0.66 to 1.02; p = 0.07)].

Western blotting analysis of phospholamban (encoded by Pln ) phosphorylation showed a trend for increased phosphorylation in hearts from 3-month-old C. mdx 62 mice ( P= 0.07; Fig.

This effect was specific as c-MYC amplified cells lines were not resistant for Aurora kinase inhibition but rather showed a trend towards synthetic lethality, which is in agreement with our previous findings ( Supplementary Fig. 26 , p=0.07).

Comparing behavioral results at 24-hour and 12-hour post learning A mixed ANOVA to investigate change in memory performance across all the sessions with schema learning (schema, no-schema), and test session (12 and 24 hours) as the within-participant factors, and consolidation condition (sleep, wake) as the between-participant factor, showed a trend for the better performance in the sleep group, F (1,51) = 3.424, p > 0.070, η p 2 = 0.063, and a trend for schema by sleep interaction, F (1,51) = 3.559, p > 0.065, η p 2 < 0.065, with no other significant main effects or interactions ( Figure 6A ).

The 10 METH abusers who remained abstinent showed a trend for lower baseline D2R availability (p < 0.07) and less MPH-induced DA release (treatment × diagnosis, p < 0.07) in caudate than the controls.

It is noteworthy that these five studies showed a trend towards heterogeneity (I-squared = 53.98%, p = 0.07).

The naturally logarithmically transformed SIF showed a trend for being higher in cases with clinical evidence of DSP ( P = 0.07).

showed a trend to improved PFS when they compared HL patients who developed extensive chronic GvHD and those who did not (71% versus 44%, P = .07) [ 32 ].

Moreover, the authors added that SLL in patients correlated significantly with WG ( P < .001) and showed a trend for an association with BMI gains ( P < .07).

While most relevant baseline characteristics including symptoms and proportion of residual MR exceeding moderate grade did not differ significantly between the groups, LARR‐patients showed a trend towards lower BNP at discharge and at 1 month follow‐up [319 (197.8 to 526) vs. 560 (279.3 to 929), P = 0.07, and 287.5 (191.3 to 386.3) vs. 506.5 (223.3 to 935.5), P = 0.06, respectively].

PS supplementation showed a trend towards improving perceived stress levels during teeing-off (mean: pre-test 5.8 ± 2.0, post-test 4.0 ± 2.0, p = 0.07), whereas stress levels remained unchanged in the placebo group (mean: pre-test: 5.1 ± 2.0, post-test: 5.1 ± 3.1).

Subsyndromal PTSD subjects showed a trend for significantly higher heart-rate reactivity in comparison to non-PTSD participants ( p =.07), but not healthy controls ( p =.13).

While no significant differences in viral clearance were observed at six months, smokers showed a trend toward worse outcomes at two years ( p= 0.07).

Serum triglyceride levels showed a trend toward a main effect of E2 treatment by two‐way ANOVA ( p = 0.07; Figure 5F), with lower levels in both E2‐treated groups compared with their respective vehicle controls.

While HRQoL increased in all patients, obese patients showed a trend towards an even greater improvement of mental HRQoL ( p = 0.07) vs. non- obese patients.

Patients with complications showed a trend toward lower success rates compared to those without (90.3% vs. 100%, p = 0.07), though the difference was not statistically significant.